RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Star Combo Pharma Stock

Star Combo Pharma Debt 2024

Star Combo Pharma Debt

0 AUD

Ticker

S66.AX

ISIN

AU0000004798

In 2024, Star Combo Pharma's total debt was 0 AUD, a -100% change from the -6.27 AUD total debt recorded in the previous year.

Star Combo Pharma Aktienanalyse

What does Star Combo Pharma do?

Star Combo Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Star Combo Pharma's Debt Structure

Star Combo Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Star Combo Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Star Combo Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Star Combo Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Star Combo Pharma stock

What is the debt of Star Combo Pharma this year?

Star Combo Pharma has a debt level of 0 AUD this year.

What was the debt of Star Combo Pharma compared to the previous year?

The debt of Star Combo Pharma has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Star Combo Pharma?

High debt can pose a risk for investors of Star Combo Pharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Star Combo Pharma?

Low debt means that Star Combo Pharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Star Combo Pharma affect the company?

An increase in debt of Star Combo Pharma can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Star Combo Pharma affect the company?

A reduction in debt of Star Combo Pharma can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Star Combo Pharma?

Some factors that can influence the debt of Star Combo Pharma include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Star Combo Pharma so important for investors?

The debts of Star Combo Pharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Star Combo Pharma take to change the debt?

To change the debt, Star Combo Pharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Star Combo Pharma pay?

Over the past 12 months, Star Combo Pharma paid a dividend of 0 AUD . This corresponds to a dividend yield of about 3.52 %. For the coming 12 months, Star Combo Pharma is expected to pay a dividend of 0 AUD.

What is the dividend yield of Star Combo Pharma?

The current dividend yield of Star Combo Pharma is 3.52 %.

When does Star Combo Pharma pay dividends?

Star Combo Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Star Combo Pharma?

Star Combo Pharma paid dividends every year for the past 1 years.

What is the dividend of Star Combo Pharma?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 3.52 %.

In which sector is Star Combo Pharma located?

Star Combo Pharma is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Star Combo Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Star Combo Pharma from 10/31/2024 amounting to 0.005 AUD, you needed to have the stock in your portfolio before the ex-date on 10/14/2024.

When did Star Combo Pharma pay the last dividend?

The last dividend was paid out on 10/31/2024.

What was the dividend of Star Combo Pharma in the year 2023?

In the year 2023, Star Combo Pharma distributed 0 AUD as dividends.

In which currency does Star Combo Pharma pay out the dividend?

The dividends of Star Combo Pharma are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Star Combo Pharma

Our stock analysis for Star Combo Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Star Combo Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.